The slip
PARKINSON RECEIPTno. 8557
24 Oct 2026, 10:38 UTColigodendrocytes, braak
predictionTRIM9 in oligodendrocytes tracks Braak Lewy-body stage
registeredca7750cec7b25de2
discovery+0.51 p=0.160 n=9
replication-0.17 p=0.663 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.51, p 0.160)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTf1e7101915323be010cc3fb5…
follows c81770e72282…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 8557: TRIM9 in oligodendrocytes, braak
- power
- full sample +0.16 (p 0.538, n 18), 95% CI -0.34 to +0.58. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.19 (p 0.460, n 18). does not hold up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: -0.03 (p 0.915, n 18). could be the mix.
- skeptic
- leave-one-out range +0.05 to +0.24, sign flips 0; without severely affected donors +0.16 (p 0.538, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for TRIM9 in oligodendrocytes.
case closed: nothing better to follow up.